ArticleFrontiers in public health2026
Harnessing conversational generative artificial intelligence and natural language processing to address the colorectal cancer screening adherence gap: the Azores endeavour.
Article in Frontiers in public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Organised colorectal cancer (CRC) screening reduces mortality, yet participation routinely falls short of policy targets, a gap most acute in structurally disadvantaged, insular, and rapidly ageing populations. The Azores, an outermost European Union archipelago, exemplifies this challenge: CRC accounts for 10% of regional cancer diagnoses and is the second leading oncological cause of potential years of life lost, with 2024 mortality (24.9 per 100,000) exceeding mainland Portugal. Despite a mature organised screening programme (ROCCRA), archipelago-wide participation stands at just 30.3%, with roughly one in five residents who consent and receive a home test kit never returning it. This perspective article argues that conversational artificial intelligence based on large language models (LLMs), the current generation of natural language processing (NLP) technology, capable of understanding and responding to patient concerns in real time, represents a promising approach for bridging this gap. Because the barriers identified in the literature are well, inherently dialogic, an interactive, multi-channel conversational cascade is better suited to address cognitive and operational friction than static reminders. Specifically, this paper synthesises presumed drivers of non-adherence, inferred from the literature and considered likely to apply to the Azorean context, reviews the evidence supporting conversational and voice-enabled outreach in cancer screening, and uses regional data to model the potential impact of a well-targeted voice AI deployment. Beyond the Azores, this framework illustrates how NLP-enabled conversational AI could support more responsive, equitable, and scalable public health screening programmes in geographically dispersed and underserved populations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.